Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

A Randomized Control Trial Of Anti-Inflammatory Regional Hypothermia On Urinary Continence During Robot-Assisted Radical Prostatectomy.

Huynh LM, Skarecky D, Porter J, Wagner C, Witt J, Wilson T, Lau C, Ahlering TE.

Sci Rep. 2018 Nov 5;8(1):16352. doi: 10.1038/s41598-018-34657-4.

2.

Editorial Comment on: Development of a Patient-Based Model for Estimating Operative Times for Robot-Assisted Radical Prostatectomy by Huben et al.

Skarecky D.

J Endourol. 2018 Aug;32(8):737. doi: 10.1089/end.2018.0414. Epub 2018 Jul 9. No abstract available.

PMID:
29848068
3.

Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.

Badani KK, Reddy BN, Moskowitz EJ, Paulucci DJ, Beksac AT, Martini A, Whalen MJ, Skarecky DW, Huynh LM, Ahlering TE.

Urol Oncol. 2018 Jun;36(6):310.e1-310.e6. doi: 10.1016/j.urolonc.2018.03.004. Epub 2018 Apr 4.

PMID:
29625782
4.

Predictive modelling of 2-year potency outcomes using a novel 90-day erection fullness scale after robot-assisted radical prostatectomy.

Huynh LM, Osann K, Skarecky D, Ahlering TE.

BJU Int. 2018 Aug;122(2):249-254. doi: 10.1111/bju.14190. Epub 2018 Apr 14.

PMID:
29520949
5.

Electronic health record problem lists: accurate enough for risk adjustment?

Daskivich TJ, Abedi G, Kaplan SH, Skarecky D, Ahlering T, Spiegel B, Litwin MS, Greenfield S.

Am J Manag Care. 2018 Jan 1;24(1):e24-e29.

6.

Diminished long-term recovery of peak flow rate (PFR) after robotic prostatectomy in men with baseline PFR <10 mL/s and incidental association with high-risk prostate cancer.

Gordon A, Skarecky D, Babaian KN, Dhaliwal H, Ahlering TE.

Low Urin Tract Symptoms. 2019 Jan;11(1):78-84. doi: 10.1111/luts.12199. Epub 2017 Nov 29.

PMID:
29193833
7.

Editorial Comment to Overactive bladder is a negative predictor of achieving continence after robot-assisted radical prostatectomy.

Skarecky DW.

Int J Urol. 2017 Oct;24(10):756. doi: 10.1111/iju.13450. No abstract available.

8.

Analysis of Accessory Pudendal Artery Transection on Erections During Robot-Assisted Radical Prostatectomy.

Williams SB, Morales BE, Huynh LM, Osann K, Skarecky DW, Ahlering TE.

J Endourol. 2017 Nov;31(11):1170-1175. doi: 10.1089/end.2017.0542. Epub 2017 Oct 4.

9.

Hypothermic Cooling Measured by Thermal Magnetic Resonance Imaging; Feasibility and Implications for Virtual Imaging in the Urogenital Pelvis.

Skarecky D, Yu H, Linehan J, Morales B, Su MY, Fwu P, Ahlering T.

Urology. 2017 Oct;108:220-224. doi: 10.1016/j.urology.2017.07.006. Epub 2017 Jul 18.

10.

Association of comorbid disease burden at diagnosis with higher tumor grade in men with non-metastatic prostate cancer.

Daskivich TJ, Dru CJ, Skarecky D, Ahlering T, Freedland SJ.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):343-347. doi: 10.1038/pcan.2017.22. Epub 2017 Apr 25.

PMID:
28440321
11.

Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study.

Kim DK, Parihar JS, Kwon YS, Kim S, Shinder B, Lee N, Farber N, Ahlering T, Skarecky D, Yuh B, Ruel N, Kim WJ, Rha KH, Kim IY.

Asian J Androl. 2018 Jan-Feb;20(1):9-14. doi: 10.4103/1008-682X.196852.

12.

Limitations of the National Comprehensive Cancer Network® (NCCN®) Guidelines for Prediction of Limited Life Expectancy in Men with Prostate Cancer.

Daskivich TJ, Wood LN, Skarecky D, Ahlering T, Freedland S.

J Urol. 2017 Feb;197(2):356-362. doi: 10.1016/j.juro.2016.08.096. Epub 2016 Aug 28.

PMID:
27582436
13.

Quantification of Long-term Stability and Specific Relief of Lower Urinary Tract Symptoms (LUTS) After Robot-assisted Radical Prostatectomy.

Gordon A, Skarecky D, Osann K, Eichel L, Dhaliwal H, Morales B, Ahlering T.

Urology. 2016 Jul;93:97-103. doi: 10.1016/j.urology.2016.03.028. Epub 2016 Mar 30.

14.

The importance of surgical margins in prostate cancer.

Sooriakumaran P, Dev HS, Skarecky D, Ahlering T.

J Surg Oncol. 2016 Mar;113(3):310-5. doi: 10.1002/jso.24109. Epub 2016 Mar 23. Review.

PMID:
27004601
15.

Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.

Kwon YS, Ha YS, Modi PK, Salmasi A, Parihar JS, Patel N, Faiena I, May M, Lee DI, Llukani E, Patrick T, Rha KH, Ahlering T, Skarecky D, Ahn H, Choi SK, Park S, Jeon SS, Ou YC, Eun D, Manucha V, Albala D, Badani K, Yuh B, Ruel N, Kim TH, Kwon TG, Marchalik D, Hwang J, Kim WJ, Kim IY.

BMC Urol. 2015 Aug 1;15:79. doi: 10.1186/s12894-015-0070-1.

16.

Analysis of Improved Urinary Peak Flow Rates After Robot-Assisted Radical Prostatectomy.

Skarecky D, Gordon A, Babaian KN, Dhaliwal H, Morales B, Ahlering TE.

J Endourol. 2015 Oct;29(10):1152-8. doi: 10.1089/end.2015.0353. Epub 2015 Jul 27.

PMID:
26076987
18.

Surgical margin length and location affect recurrence rates after robotic prostatectomy.

Dev HS, Wiklund P, Patel V, Parashar D, Palmer K, Nyberg T, Skarecky D, Neal DE, Ahlering T, Sooriakumaran P.

Urol Oncol. 2015 Mar;33(3):109.e7-13. doi: 10.1016/j.urolonc.2014.11.005. Epub 2014 Dec 13.

PMID:
25512161
19.

A comparative analysis of complications after robot-assisted radical prostatectomy for men aged ≤69 and ≥70 years.

Babaian KN, Skarecky D, Liss MA, Osann K, Lusch A, Ahlering TE.

J Endourol. 2014 Dec;28(12):1435-8. doi: 10.1089/end.2014.0234.

PMID:
25211698
20.

Long-term outcomes in severe lower urinary tract symptoms in men undergoing robotic-assisted radical prostatectomy.

Gordon A, Skarecky DW, Ahlering T.

Urology. 2014 Oct;84(4):826-31. doi: 10.1016/j.urology.2014.05.052. Epub 2014 Aug 5.

PMID:
25102787

Supplemental Content

Loading ...
Support Center